MAP2K7 and nonpapillary renal cell carcinoma: Although RKIP was best studied for its inhibition of Raf-initiated activation of MEK [50], an upstream kinase of ERK, it does not appear that RKIP suppresses ccRCC tumorigenesis mainly via inhibiting the Raf-MEK-ERK pathway (Supplementary Fig. 1, data not shown).